RegisterLogin

RTx-303

CAT: 0804-HY-179219SSize: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-179219SSize:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
RTx-303 is an orally active, selective DNA polymerase θ (Polθ) inhibitor (IC50 = 5.1 nM) . RTx-303 exhibits significantly high cellular potency and strongly potentiates PARPi in BRCA1/2 mutant cells and patient-derived xenograft models. RTx-303 can be used for the study of BRCA2-mutated breast cancer[1].
CAS Number
[3035072-99-9]
UNSPSC
12352005
Target
DNA/RNA Synthesis
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
CN(C)C[C@@H](O)CN(C1=O)CCN1C2=C(OC(N(C([2H])([2H])[2H])C3=CC=C(F)C=C3)=O)C(C(F)(F)F)=CC(C(F)(F)F)=C2
Molecular Formula
C24H22D3F7N4O4
Molecular Weight
569.49
References & Citations
[1]Chandramouly G, et al. RTx-303, an Orally Bioavailable Polθ Polymerase Inhibitor That Potentiates PARP Inhibitors in BRCA Mutant Tumors. J Med Chem. 2025 Nov 13;68 (21) :22196-22215.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-161431-01RTx-152
HY-P991351RTX-002
HY-161430-01RTx-161
HY-164002PF-303
HY-P991276FM-303
HY-16953-01JNJ 303
HY-W264454Antibacterial agent 303
HY-W061043DOV-216,303
HY-W953744CRBN ligand-303
HY-18332C-01DOV-216,303 (Free Base)

Alternative Products

CatalogName
T209740-01RTx-152
T9901A-1582-01RTX-002
T209721-01RTx-161
M0380SWarmStart RTx Reverse Transcriptase
452867-01JNJ 303
MBS1048628-01Recombinant Heteractis crispa Cytolysin RTX-A
MBS5813154TAS-303
T9901A-054-01ABBV-303
MBS5812934PF-303
iha-012Wyoming 303

Popular Products